pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4481 |
Genomic Coordinates | chr10: 12653138 - 12653197 |
Description | Homo sapiens miR-4481 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4481 | ||||||||||||
Sequence | 1| GGAGUGGGCUGGUGGUU |17 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Illumina | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | EP300 | ||||||||||||||||||||
Synonyms | KAT3B, RSTS2, p300 | ||||||||||||||||||||
Description | E1A binding protein p300 | ||||||||||||||||||||
Transcript | NM_001429 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on EP300 | |||||||||||||||||||||
3'UTR of EP300 (miRNA target sites are highlighted) |
>EP300|NM_001429|3'UTR 1 AGACACCTTGTAGTATTTTGGGAGCAAAAAAATTATTTTCTCTTAACAAGACTTTTTGTACTGAAAACAATTTTTTTGAA 81 TCTTTCGTAGCCTAAAAGACAATTTTCCTTGGAACACATAAGAACTGTGCAGTAGCCGTTTGTGGTTTAAAGCAAACATG 161 CAAGATGAACCTGAGGGATGATAGAATACAAAGAATATATTTTTGTTATGGCTGGTTACCACCAGCCTTTCTTCCCCTTT 241 GTGTGTGTGGTTCAAGTGTGCACTGGGAGGAGGCTGAGGCCTGTGAAGCCAAACAATATGCTCCTGCCTTGCACCTCCAA 321 TAGGTTTTATTATTTTTTTTAAATTAATGAACATATGTAATATTAATAGTTATTATTTACTGGTGCAGATGGTTGACATT 401 TTTCCCTATTTTCCTCACTTTATGGAAGAGTTAAAACATTTCTAAACCAGAGGACAAAAGGGGTTAATGTTACTTTAAAA 481 TTACATTCTATATATATATAAATATATATAAATATATATTAAAATACCAGTTTTTTTTCTCTGGGTGCAAAGATGTTCAT 561 TCTTTTAAAAAATGTTTAAAAAAAAAAAAAAACTGCCTTTCTTCCCCTCAAGTCAACTTTTGTGCTCCAGAAAATTTTCT 641 ATTCTGTAAGTCTGAGCGTAAAACTTCAAGTATTAAAATAATTTGTACATGTAGAGAGAAAAATGACTTTTTCAAAAATA 721 TACAGGGGCAGCTGCCAAATTGATGTATTATATATTGTGGTTTCTGTTTCTTGAAAGAATTTTTTTCGTTATTTTTACAT 801 CTAACAAAGTAAAAAAATTAAAAAGAGGGTAAGAAACGATTCCGGTGGGATGATTTTAACATGCAAAATGTCCCTGGGGG 881 TTTCTTCTTTGCTTGCTTTCTTCCTCCTTACCCTACCCCCCACTCACACACACACACACACACACACACACACACACACA 961 CACACACTTTCTATAAAACTTGAAAATAGCAAAAACCCTCAACTGTTGTAAATCATGCAATTAAAGTTGATTACTTATAA 1041 ATATGAACTTTGGATCACTGTATAGACTGTTAAATTTGATTTCTTATTACCTATTGTTAAATAAACTGTGTGAGACAGAC 1121 A Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | MCF7 | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1395164. RNA binding protein: AGO. Condition:MCF7 AGO HITS-CLIP Replicate 2
... - Pillai MM; Gillen AE; Yamamoto TM; Kline E; et al., 2014, Breast cancer research and treatment. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Pillai MM; Gillen AE; Yamamoto TM; Kline E; et al. - Breast cancer research and treatment, 2014
miRNAs regulate the expression of genes in both normal physiology and disease. While miRNAs have been demonstrated to play a pivotal role in aspects of cancer biology, these reports have generally focused on the regulation of single genes. Such single-gene approaches have significant limitations, relying on miRNA expression levels and heuristic predictions of mRNA-binding sites. This results in only circumstantial evidence of miRNA-target interaction and typically leads to large numbers of false positive predictions. Here, we used a genome-wide approach (high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation, HITS-CLIP) to define direct miRNA-mRNA interactions in three breast cancer subtypes (estrogen receptor positive, Her2 amplified, and triple negative). Focusing on steroid receptor signaling, we identified two novel regulators of the ER pathway (miR-9-5p and miR-193a/b-3p), which together target multiple genes involved in ER signaling. Moreover, this approach enabled the definition of miR-9-5p as a global regulator of steroid receptor signaling in breast cancer. We show that miRNA targets and networks defined by HITS-CLIP under physiologic conditions are predictive of patient outcomes and provide global insight into miRNA regulation in breast cancer.
LinkOut: [PMID: 24906430]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Cardiac Tissues |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM2202479. RNA binding protein: AGO2. Condition:S4_LV_29yo_Male_AGO2_bound_RNA
HITS-CLIP data was present in GSM2202480. RNA binding protein: AGO2. Condition:S5_LV_36yo_Male_AGO2_bound_RNA
HITS-CLIP data was present in GSM2202477. RNA binding protein: AGO2. Condition:S2_LV_25yo_Male_AGO2_bound_RNA
HITS-CLIP data was present in GSM2202476. RNA binding protein: AGO2. Condition:S1_LV_54yo_Male_AGO2_bound_RNA
... - Spengler RM; Zhang X; Cheng C; McLendon JM; et al., 2016, Nucleic acids research. |
Article |
Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP.
- Spengler RM; Zhang X; Cheng C; McLendon JM; et al.- Nucleic acids research, 2016
MicroRNAs (miRs) have emerged as key biological effectors in human health and disease. These small noncoding RNAs are incorporated into Argonaute (Ago) proteins, where they direct post-transcriptional gene silencing via base-pairing with target transcripts. Although miRs have become intriguing biological entities and attractive therapeutic targets, the translational impacts of miR research remain limited by a paucity of empirical miR targeting data, particularly in human primary tissues. Here, to improve our understanding of the diverse roles miRs play in cardiovascular function and disease, we applied high-throughput methods to globally profile miR:target interactions in human heart tissues. We deciphered Ago2:RNA interactions using crosslinking immunoprecipitation coupled with high-throughput sequencing (HITS-CLIP) to generate the first transcriptome-wide map of miR targeting events in human myocardium, detecting 4000 cardiac Ago2 binding sites across >2200 target transcripts. Our initial exploration of this interactome revealed an abundance of miR target sites in gene coding regions, including several sites pointing to new miR-29 functions in regulating cardiomyocyte calcium, growth and metabolism. Also, we uncovered several clinically-relevant interactions involving common genetic variants that alter miR targeting events in cardiomyopathy-associated genes. Overall, these data provide a critical resource for bolstering translational miR research in heart, and likely beyond.
LinkOut: [PMID: 27418678]
|
CLIP-seq Support 1 for dataset GSM1395164 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | MCF7 / MCF7 AGO HITS-CLIP Replicate 2 |
Location of target site | ENST00000263253.7 | 3UTR | ACUCACACACACACACACACACACACACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24906430 / GSE57855 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
84 hsa-miR-4481 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT100715 | TJAP1 | tight junction associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT183589 | ZC3H11A | zinc finger CCCH-type containing 11A | ![]() |
![]() |
2 | 2 | ||||||
MIRT338033 | DAZAP2 | DAZ associated protein 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT395796 | SPCS3 | signal peptidase complex subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443947 | LRIT3 | leucine rich repeat, Ig-like and transmembrane domains 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT450580 | HIST1H2BG | histone cluster 1 H2B family member g | ![]() |
![]() |
2 | 6 | ||||||
MIRT451617 | MEIS3P1 | Meis homeobox 3 pseudogene 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452331 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453279 | EFTUD2 | elongation factor Tu GTP binding domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455212 | GNL1 | G protein nucleolar 1 (putative) | ![]() |
![]() |
2 | 2 | ||||||
MIRT455470 | LYPLA2 | lysophospholipase II | ![]() |
![]() |
2 | 2 | ||||||
MIRT456503 | PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456687 | LDB1 | LIM domain binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456915 | DDA1 | DET1 and DDB1 associated 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457603 | IDS | iduronate 2-sulfatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT457848 | RNASEH2B | ribonuclease H2 subunit B | ![]() |
![]() |
2 | 4 | ||||||
MIRT458455 | RPRM | reprimo, TP53 dependent G2 arrest mediator homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT460179 | UNK | unkempt family zinc finger | ![]() |
![]() |
2 | 6 | ||||||
MIRT461465 | SLC19A3 | solute carrier family 19 member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464739 | UBE2Q1 | ubiquitin conjugating enzyme E2 Q1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465279 | TRIM28 | tripartite motif containing 28 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468450 | SETD1B | SET domain containing 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT468620 | SUMO1 | small ubiquitin-like modifier 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT469152 | RNF121 | ring finger protein 121 | ![]() |
![]() |
2 | 2 | ||||||
MIRT470073 | PTGES2 | prostaglandin E synthase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT470172 | PSMD11 | proteasome 26S subunit, non-ATPase 11 | ![]() |
![]() |
2 | 4 | ||||||
MIRT473156 | MLLT1 | MLLT1, super elongation complex subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT474308 | LAMC1 | laminin subunit gamma 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474782 | KIAA0895L | KIAA0895 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT476484 | GATAD2A | GATA zinc finger domain containing 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT477613 | EFNA3 | ephrin A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479525 | CDCA4 | cell division cycle associated 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479973 | CARD10 | caspase recruitment domain family member 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480410 | C19orf47 | chromosome 19 open reading frame 47 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480426 | C17orf85 | nuclear cap binding subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483573 | SYT2 | synaptotagmin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483664 | QSOX2 | quiescin sulfhydryl oxidase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT484532 | POLD3 | DNA polymerase delta 3, accessory subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT484616 | SIX3 | SIX homeobox 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT485897 | ZFP36 | ZFP36 ring finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT486505 | MYH11 | myosin heavy chain 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487505 | GRK5 | G protein-coupled receptor kinase 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488852 | UBTF | upstream binding transcription factor, RNA polymerase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT489464 | MSC | musculin | ![]() |
![]() |
2 | 2 | ||||||
MIRT491170 | LRP3 | LDL receptor related protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496627 | TMEM67 | transmembrane protein 67 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497616 | ANG | angiogenin | ![]() |
![]() |
2 | 2 | ||||||
MIRT497766 | KIAA0895 | KIAA0895 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499680 | MRE11A | MRE11 homolog, double strand break repair nuclease | ![]() |
![]() |
2 | 6 | ||||||
MIRT499774 | SLC29A2 | solute carrier family 29 member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501745 | NSD1 | nuclear receptor binding SET domain protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT504995 | ZNF652 | zinc finger protein 652 | ![]() |
![]() |
2 | 2 | ||||||
MIRT511664 | HIST1H3C | histone cluster 1 H3 family member c | ![]() |
![]() |
2 | 2 | ||||||
MIRT511690 | HIST1H2BO | histone cluster 1 H2B family member o | ![]() |
![]() |
2 | 4 | ||||||
MIRT511703 | HIST1H2BL | histone cluster 1 H2B family member l | ![]() |
![]() |
2 | 4 | ||||||
MIRT511734 | HIST1H2BE | histone cluster 1 H2B family member e | ![]() |
![]() |
2 | 8 | ||||||
MIRT512858 | TBC1D13 | TBC1 domain family member 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT513444 | EMP1 | epithelial membrane protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT515681 | TFPI | tissue factor pathway inhibitor | ![]() |
![]() |
2 | 2 | ||||||
MIRT523529 | GLUL | glutamate-ammonia ligase | ![]() |
![]() |
2 | 2 | ||||||
MIRT525546 | PHB2 | prohibitin 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT526209 | SNX24 | sorting nexin 24 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531554 | SRD5A1 | steroid 5 alpha-reductase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533764 | TMEM135 | transmembrane protein 135 | ![]() |
![]() |
2 | 2 | ||||||
MIRT545582 | SNRPA1 | small nuclear ribonucleoprotein polypeptide A' | ![]() |
![]() |
2 | 2 | ||||||
MIRT552434 | ZNF460 | zinc finger protein 460 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561159 | BCL2L12 | BCL2 like 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562345 | EXOSC2 | exosome component 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570659 | KDM6B | lysine demethylase 6B | ![]() |
![]() |
2 | 2 | ||||||
MIRT571076 | TCHHL1 | trichohyalin like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT571330 | TPCN2 | two pore segment channel 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT571603 | TOB2 | transducer of ERBB2, 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573013 | RPP25 | ribonuclease P and MRP subunit p25 | ![]() |
![]() |
2 | 2 | ||||||
MIRT609041 | EP300 | E1A binding protein p300 | ![]() |
![]() |
2 | 2 | ||||||
MIRT613398 | DNAH17 | dynein axonemal heavy chain 17 | ![]() |
![]() |
2 | 2 | ||||||
MIRT635589 | TTC9C | tetratricopeptide repeat domain 9C | ![]() |
![]() |
2 | 2 | ||||||
MIRT661118 | FPR1 | formyl peptide receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690103 | PNMA2 | paraneoplastic Ma antigen 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT694972 | PLAC8 | placenta specific 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695515 | ALPI | alkaline phosphatase, intestinal | ![]() |
![]() |
2 | 2 | ||||||
MIRT695578 | ASB16 | ankyrin repeat and SOCS box containing 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT699570 | SIT1 | signaling threshold regulating transmembrane adaptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT701991 | MIER3 | MIER family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725464 | GRAP2 | GRB2-related adaptor protein 2 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|